D S Hewick

871 total citations
32 papers, 641 citations indexed

About

D S Hewick is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, D S Hewick has authored 32 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Pharmacology. Recurrent topics in D S Hewick's work include Drug Transport and Resistance Mechanisms (9 papers), Ion channel regulation and function (8 papers) and Pharmacogenetics and Drug Metabolism (7 papers). D S Hewick is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Ion channel regulation and function (8 papers) and Pharmacogenetics and Drug Metabolism (7 papers). D S Hewick collaborates with scholars based in United Kingdom, United States and Mexico. D S Hewick's co-authors include T. A. Moreland, Ian H. Stevenson, Alexander M. M. Shepherd, John McEwen, James R. Fouts, A H Beckett, Neil A Murray, Sally Hopwood, David J.K. Balfour and S. Ogston and has published in prestigious journals such as British Journal of Pharmacology, Psychological Medicine and Biochemical Pharmacology.

In The Last Decade

D S Hewick

32 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D S Hewick United Kingdom	11	262	140	117	91	79	32	641
H.F. Woods United Kingdom	8	328 1.3×	126 0.9×	98 0.8×	130 1.4×	102 1.3×	9	708
Edward C. Conradi United States	13	211 0.8×	70 0.5×	98 0.8×	88 1.0×	164 2.1×	19	658
D. A. Stopher United Kingdom	10	124 0.5×	125 0.9×	140 1.2×	55 0.6×	128 1.6×	18	563
John J. Schrogie United States	14	158 0.6×	173 1.2×	86 0.7×	67 0.7×	154 1.9×	34	688
Richard P. Koshakji United States	14	145 0.6×	89 0.6×	145 1.2×	65 0.7×	79 1.0×	22	594
Gwyn H. Evans United States	11	226 0.9×	160 1.1×	180 1.5×	121 1.3×	205 2.6×	12	921
Ermelinda Sakmar United States	18	171 0.7×	103 0.7×	67 0.6×	58 0.6×	148 1.9×	40	909
H.‐P. KRIEMLER Switzerland	12	158 0.6×	189 1.4×	60 0.5×	117 1.3×	135 1.7×	21	658
John S. Dutcher United States	15	174 0.7×	197 1.4×	78 0.7×	69 0.8×	54 0.7×	43	863
William Schary United States	10	220 0.8×	113 0.8×	63 0.5×	89 1.0×	117 1.5×	26	623

Countries citing papers authored by D S Hewick

Since Specialization

Citations

This map shows the geographic impact of D S Hewick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D S Hewick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D S Hewick more than expected).

Fields of papers citing papers by D S Hewick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D S Hewick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D S Hewick. The network helps show where D S Hewick may publish in the future.

Co-authorship network of co-authors of D S Hewick

This figure shows the co-authorship network connecting the top 25 collaborators of D S Hewick. A scholar is included among the top collaborators of D S Hewick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D S Hewick. D S Hewick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hewick, D S, et al.. (1992). Digoxin-specific Fab fragments impair renal function in the rabbit. Journal of Pharmacy and Pharmacology. 44(10). 867–869. 5 indexed citations

Hewick, D S, et al.. (1992). The Plasma Disposition and Renal Elimination of Digoxinspecific Fab Fragments and Digoxin in the Rabbit. Journal of Pharmacy and Pharmacology. 44(10). 796–800. 21 indexed citations

Hewick, D S, et al.. (1991). The plasma kinetics of digoxin-specific Fab fragments and digoxin in the rabbit. Journal of Pharmacy and Pharmacology. 43(11). 807–810. 3 indexed citations

Ostenfeld, Thor, et al.. (1989). The plasma disposition of sheep antibody (Fab) Fragments in the guinea-pig and rabbit. Journal of Pharmacy and Pharmacology. 41(11). 786–788. 2 indexed citations

Stevenson, Ian H., et al.. (1988). The use of an enzyme-linked immunosorbent assay to study the disposition of sheep digoxin-specific immunoglobulin G and Fab fragments in the rat.. PubMed. 74(3). 489–93. 7 indexed citations

Hewick, D S, et al.. (1987). Sodium nitroprusside: pharmacological aspects of its interaction with hydroxocobalamin and thiosulphate. Journal of Pharmacy and Pharmacology. 39(2). 113–117. 3 indexed citations

Griffiths, Nina M., D S Hewick, Justin Lamb, & Ian H. Stevenson. (1985). The influence of digoxin antibodies on digoxin disposition and effect: studies in guinea-pigs and HeLa cells.. PubMed. 84(1). 157–63. 4 indexed citations

Tavendale, Roger, et al.. (1985). The biliary elimination of amaranth, indocyanine green and nitrazepam in germ-free rats. Biochemical Pharmacology. 34(6). 857–863. 3 indexed citations

Griffiths, Nina M., D S Hewick, & Ian H. Stevenson. (1984). The effect of immunization with digoxin-specific antibodies on digoxin disposition in the mouse. Biochemical Pharmacology. 33(19). 3041–3046. 13 indexed citations

10.

Murray, Neil A, et al.. (1981). Studies on the disposition of Li+ in the guinea-pig and rat. Psychopharmacology. 74(4). 374–378. 1 indexed citations

11.

Hewick, D S & Victoria Shaw. (1978). Tissue distribution of radioactivity after injection of [14C]nitrazepam in young and old rats. Journal of Pharmacy and Pharmacology. 30(1). 318–319. 8 indexed citations

12.

Hewick, D S & Victoria Shaw. (1978). The importance of the intestinal microflora in nitrazepam metabolism in the rat [proceedings].. PubMed. 62(3). 427P–427P. 5 indexed citations

13.

Shepherd, Alexander M. M., D S Hewick, T. A. Moreland, & Ian H. Stevenson. (1977). Age as a determinant of sensitivity to warfarin.. British Journal of Clinical Pharmacology. 4(3). 315–320. 190 indexed citations

14.

Hewick, D S & T. A. Moreland. (1975). Proceedings: An NADPH dependent warfarin reductase in human and rat liver and kidney soluble fraction.. British Journal of Pharmacology. 53(3). 441. 1 indexed citations

15.

Hewick, D S, T. A. Moreland, Alexander M. M. Shepherd, & Ian H. Stevenson. (1975). The effect of age on the sensitivity to warfarin sodium. British Journal of Clinical Pharmacology. 2(2). 16 indexed citations

16.

Moreland, T. A. & D S Hewick. (1975). Studies on a ketone reductase in human and rat liver and kidney soluble fraction using warfarin as a substrate. Biochemical Pharmacology. 24(21). 1953–1957. 50 indexed citations

17.

Hewick, D S & John McEwen. (1973). Plasma half-lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man. Journal of Pharmacy and Pharmacology. 25(6). 458–465. 96 indexed citations

18.

Hewick, D S. (1972). The plasma half-lives of the enantiomers of warfarin in warfarin-resistant and warfarin-susceptible rats. Journal of Pharmacy and Pharmacology. 24(8). 661–662. 25 indexed citations

19.

Hewick, D S & James R. Fouts. (1970). Effects of storage on hepatic microsomal cytochromes and substrate-induced difference spectra. Biochemical Pharmacology. 19(2). 457–472. 40 indexed citations

20.

Beckett, A H & D S Hewick. (1967). The N-oxidation of chlorpromazine in vitro—the major metabolic route using rat liver microsomes. Journal of Pharmacy and Pharmacology. 19(2). 134–136. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact